The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GSK5764227 (GSK’227) for the treatment of adult patients with relapsed or refractory (R/R) osteosarcoma who have ...

Zinplava ™ (bezlotoxumab) injection will be discontinued as of January 31, 2025, according to the Food and Drug Administration’s (FDA) drug shortages tracker.

While vaccination is the best way to protect against whooping cough, vaccination rates in children have fallen ...

HealthDay News — Gestational exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk for childhood chronic kidney disease (CHD), although the association is not ...

Clinical practice guideline also presents recommendations for specialist care and primary care of patients with Alzheimer disease, dementia.

HealthDay News — Among privately insured US adolescents who identified as transgender and gender-diverse (TGD), receipt of puberty blockers and hormones was rare from 2018 to 2022, according to a ...